Skip to content

Clinical trials

Disease Progression trials in Italy

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Disease Progression Country / region: Italy Clear all

26 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20071
20091
20112
20132
20151
20162
20171
20181
20192
20201
20211
20222
20231
20243
20251
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed9
Recruiting4
Unknown status4
Active, not recruiting3
Terminated3
Not yet recruiting2
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Heidelberg University3
AGC Biologics S.p.A.2
IRCCS San Raffaele2
AVEO Pharmaceuticals, Inc.1
Azienda Ospedaliero-Universitaria di Modena1
Biogen1
Biomea Fusion Inc.1
Eli Lilly and Company1
Ferrer Internacional S.A.1
Fondazione Don Carlo Gnocchi ETS1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Disease Progression26
Kidney Failure, Chronic3
Cardiovascular Diseases2
Diabetes Mellitus, Type 12
Disease2
Hypertrophy, Left Ventricular2
Multiple Sclerosis2
Neoplasm Metastasis2
Ovarian Neoplasms2
Renal Insufficiency, Chronic2

Trials

Showing 76 to 26 of 26. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.